NewsHealth

LI hospitals, patients cope with drug shortages

Nikki Abbondondelo, 51, of Bethpage is battling ovarian

Nikki Abbondondelo, 51, of Bethpage is battling ovarian cancer and relies on Doxil, a chemotherapy drug on the short-supply list. She says she may have to just wait it out until more comes in. (Aug. 24, 2011) Photo Credit: Newsday/Karen Wiles Stabile

More than 180 medications -- from those treating cancer and childhood leukemia to surgical anesthetics and painkillers -- have appeared on the U.S. Food and Drug Administration's list of critical shortages this year. (Aug. 24, 2011)

Nikki Abbondondelo, 51, of Bethpage is battling ovarian
Photo Credit: Newsday/Karen Wiles Stabile

Nikki Abbondondelo, 51, of Bethpage is battling ovarian cancer and relies on Doxil, a chemotherapy drug on the short-supply list. She says she may have to just wait it out until more comes in. (Aug. 24, 2011)

Nikki Abbondondelo, 51, of Bethpage, at home with
Photo Credit: Newsday/Karen Wiles Stabile

Nikki Abbondondelo, 51, of Bethpage, at home with her husband Joe, is battling ovarian cancer and relies on Doxil, a chemotherapy drug on the short-supply list. “It’s very nerve-racking when you know you’re doing very well on a drug and you can’t get it,” she said. "This is life-giving treatment for me and everybody else on it." (Aug. 24, 2011)

The Doxil shortage is due to
Photo Credit: Newsday/Karen Wiles Stabile

The Doxil shortage is due to "a manufacturing problem related to capacity," said Lisa Vaga, spokeswoman for Janssen Products, the biotech firm that makes the drug used primarily to treat ovarian cancer. (Aug. 24, 2011)

Photo Credit: Newsday/Karen Wiles Stabile

"We are all being impacted. Every single hospital, regardless of size, is being affected" by the shortage of life-saving medicines, said Marcelle Levy-Santor, right, pharmacy director at Nassau University Medical Center in East Meadow. Standing next to Levy-Santor is pharmacy technician Rukhsana Ahmed, who fills orders under her supervision. (Aug. 24, 2011)

The Doxil shortage is due to
Photo Credit: Newsday/Karen Wiles Stabile

The Doxil shortage is due to "a manufacturing problem related to capacity," said Lisa Vaga, spokeswoman for Janssen Pharmaceuticals, the biotech firm that makes the ovarian cancer drug. The drug is one of many in short supply across the United States. (Aug. 24, 2011)

Photo Credit: Newsday/Karen Wiles Stabile

"We are all being impacted. Every single hospital, regardless of size, is being affected" by the shortage of life-saving medicines, said Marcelle Levy-Santor, pharmacy director at Nassau University Medical Center in East Meadow. Levy-Santor holds a vial of Doxil, the ovarian cancer drug that is in short supply. (Aug. 24, 2011)

More news

By using this site, you agree to our Privacy policy.

OK
Sorry to interrupt...

Your first 5 are free

Access to Newsday is free for Optimum customers.

Please enjoy 5 complimentary views to articles, photos, and videos during the next 30 days.

LOGIN SUBSCRIBE